The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study
- Conditions
- Breast Cancer
- Registration Number
- NCT06220630
- Lead Sponsor
- First Affiliated Hospital, Sun Yat-Sen University
- Brief Summary
The goal of this observational study is to investigate the features in Chinese male breast cancer (MBC) patients. The main question it aims to answer is:
* The characteristics, treatment patterns and prognosis of Chinese MBC patients. The clinicopathological characteristics, treatment information and follow-up data of participants will be extracted from a Chinese national database (Chinese Society of Clinical Oncology Breast Cancer database) and other involved Chinese centers.
Researchers will investigate the features, survival associated factors and other relevant factors of this population.
- Detailed Description
The goal of this observational study is to investigate the features in Chinese male breast cancer (MBC) patients. The main question it aims to answer is:
* The characteristics, treatment patterns and prognosis of Chinese MBC patients. The clinicopathological characteristics, treatment information and follow-up data of participants will be extracted from a Chinese national database (Chinese Society of Clinical Oncology Breast Cancer database) and other involved Chinese centers.
Researchers will investigate the features, survival associated factors and other relevant factors of this population.
The collected variables included: survival time, survival status, year of diagnosis, age, stage, molecular subtype statuses, histology, grade, and surgery, radiotherapy and systemic therapies utilization.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Male
- Target Recruitment
- 1200
- Biological sex is male;
- Microscopically diagnosed as primary breast cancer.
- Presence of skin-origin malignancy on the breast.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival From the time of diagnosis to August 1, 2024 (anticipated). The duration between the date of the first pathologic diagnosis and death from any cause or last follow-up.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
First affiliated hospital of Sun Yat-sen university
🇨🇳Guangzhou, Guangdong, China
First affiliated hospital of Sun Yat-sen university🇨🇳Guangzhou, Guangdong, ChinaYuxuan Gao, MDContact+8618142846375gaoyx9@mail2.sysu.edu.cnYing Lin, MD, PhDPrincipal Investigator